Al Altomari
Former Chief Executive Officer, Barrier Therapeutics, Inc.

Armando Anido
Chief Executive Officer and President, Auxilium Pharmaceuticals, Inc.

Edwin A. Bescherer, Jr.
Retired Chief Financial Officer, Dun & Bradstreet Corporation

Philippe O. Chambon, M.D., Ph.D.
Managing Director of New Leaf Venture Partners, LLC

Rolf Classon, Chairman of the Board of Auxilium Pharmaceuticals, Inc.
Chairman of the Board of Hill-Rom Corporation, Former Chairman of the Executive Committee of Bayer HealthCare AG

Oliver Fetzer, Ph.D.
President and CEO, Cerulean Pharma Inc.

Paul A. Friedman
President and Chief Executive Officer, Incyte Corporation

Renato Fuchs, Ph.D.
Retired Senior Vice President, Manufacturing and Technical Operations, Altus Pharmaceuticals, Inc.

William T. McKee
Executive Vice President and Chief Financial Officer of Barr Pharmaceuticals, LLC, a subsidiary of Teva Pharmaceutical Industries Limited